Loguercio, C., D'Argenio, G., Delle Cave, M., Cosenza, V., Della Valle, N., Mazzacca, G., & Del Vecchio Blanco, C
Clinical Evidence for Fluid Balance Improvement Randomized controlled trials of semaglutide (SUSTAIN-6, SUSTAIN-7) and tirzepatide (SURMOUNT-1, SURMOUNT-2) demonstrate modest reductions in peripheral edema and self-reported bloating alongside weight loss
Independently tested for endotixins,sterility and benzyl alcohol level
Patients requiring higher or more frequent dosages will naturally incur greater overall expenses, but our team is dedicated to helping patients find cost-effective solutions
Consequently, their use is frequently limited in duration or combined with other agents (Kleyn et al